Literature DB >> 29742608

Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.

Marcus Unterrainer1, Daniel F Fleischmann, Simon Lindner1, Matthias Brendel1, Rainer Rupprecht2, Joerg C Tonn, Claus Belka, Peter Bartenstein, Maximilian Niyazi, Nathalie L Albert.   

Abstract

PET targeting the translocator protein (TSPO) represents an interesting approach for glioma visualization, as TSPO is highly expressed in tumor cells. We present a 32-year-old man with recurrent glioblastoma after multimodal treatment. PET with the novel TSPO ligand F-GE-180 was performed after reirradiation. Here, the previously reirradiated tumor showed a remaining circular TSPO expression. Moreover, cerebrospinal fluid dissemination was detected by a high focal uptake at the right lateral and at the fourth ventricle, whereas only a faint contrast enhancement was present in MRI. This case demonstrated the diagnostic potential of TSPO-PET for glioma imaging by visualizing even minimal disease burden.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29742608     DOI: 10.1097/RLU.0000000000002113

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  In response to: The validity of 18F-GE180 as a TSPO imaging agent.

Authors:  Nathalie L Albert; Marcus Unterrainer; Matthias Brendel; Lena Kaiser; Markus Zweckstetter; Paul Cumming; Peter Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-02       Impact factor: 9.236

2.  TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study.

Authors:  M Unterrainer; D F Fleischmann; F Vettermann; V Ruf; L Kaiser; D Nelwan; S Lindner; M Brendel; V Wenter; S Stöcklein; J Herms; V M Milenkovic; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; N L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-05       Impact factor: 9.236

3.  PET imaging in patients with brain metastasis-report of the RANO/PET group.

Authors:  Norbert Galldiks; Karl-Josef Langen; Nathalie L Albert; Marc Chamberlain; Riccardo Soffietti; Michelle M Kim; Ian Law; Emilie Le Rhun; Susan Chang; Julian Schwarting; Stephanie E Combs; Matthias Preusser; Peter Forsyth; Whitney Pope; Michael Weller; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

Review 4.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

5.  In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein.

Authors:  Nathalie L Albert; M Unterrainer; L Kaiser; M Brendel; F J Vettermann; A Holzgreve; P Bartenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-10       Impact factor: 9.236

6.  Selective, high-contrast detection of syngeneic glioblastoma in vivo.

Authors:  Richard B Banati; Paul Wilcox; Ran Xu; Grace Yin; Emily Si; Eric Taeyoung Son; Mauricio Shimizu; R M Damian Holsinger; Arvind Parmar; David Zahra; Andrew Arthur; Ryan J Middleton; Guo-Jun Liu; Arnaud Charil; Manuel B Graeber
Journal:  Sci Rep       Date:  2020-06-19       Impact factor: 4.379

7.  Membrane-embedded TSPO: an NMR view.

Authors:  Gwladys Rivière; Garima Jaipuria; Loren B Andreas; Andrei Leonov; Karin Giller; Stefan Becker; Markus Zweckstetter
Journal:  Eur Biophys J       Date:  2020-12-22       Impact factor: 1.733

8.  Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model.

Authors:  Adrien Holzgreve; Dennis Pötter; Matthias Brendel; Michael Orth; Lorraine Weidner; Lukas Gold; Maximilian A Kirchner; Laura M Bartos; Lena M Unterrainer; Marcus Unterrainer; Katja Steiger; Louisa von Baumgarten; Maximilian Niyazi; Claus Belka; Peter Bartenstein; Markus J Riemenschneider; Kirsten Lauber; Nathalie L Albert
Journal:  Biomedicines       Date:  2022-03-22

Review 9.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.